Pretreatment Neutrophil to Lymphocyte Ratio (NLR) Predicts Prognosis for Castration Resistant Prostate Cancer Patients Underwent Enzalutamide

INTRODUCTION: Nearly 80% of advanced prostate cancer patients respond to initial androgen deprivation therapy (ADT). However, ADT does not prevent the progression of prostate cancer over the long term, and the disease eventually progresses to castration-resistant prostate cancer (CRPC). Prior to the...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Biomed Res Int
Main Authors: Kumano, Yohei, Hasegawa, Yoriko, Kawahara, Takashi, Yasui, Masato, Miyoshi, Yasuhide, Matsubara, Nobuaki, Uemura, Hiroji
Format: Artigo
Sprog:Inglês
Udgivet: Hindawi 2019
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6360569/
https://ncbi.nlm.nih.gov/pubmed/30800682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/9450838
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker